Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Imaging and Radionuclide Therapy is Scopus-indexed (Q3, CiteScore 1.5), WoS ESCI. Published by Galenos Publishing House.
Checked against the index lists dated .
ISSN 2146-1414Verify ISSN ↗2147-1959Verify ISSN ↗
Publisher: Galenos Publishing House
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 248 / 361 | 31st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q3, CiteScore 1.5.
Molecular Imaging and Radionuclide Therapy is Q3 in Radiology, Nuclear Medicine and Imaging (rank 248 of 361), by CiteScore 2025.
Molecular Imaging and Radionuclide Therapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.5, which places it in quartile Q3 at the 31st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.274, quartile Q3, with an H-index of 17.
Molecular Imaging and Radionuclide Therapy is published by Galenos Publishing House. Its print ISSN is 2146-1414 and its online ISSN is 2147-1959.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular Imaging and Radionuclide Therapy has an h-index of 25 and a 2-year mean of 0.74 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #241 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Molecular Imaging and Radionuclide Therapy published 60 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from Türkiye (52.6%), Morocco (6.3%) and India (5.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.